Viral cancerogenesis of head and neck tumors;Virale kanzerogenese von kopf-hals-tumoren

Pathologe

Volumn 25, Issue 1, 2004, Pages 21-30

  Wentzensen, N ^a   Von Knebel Doeberitz, M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

EBV; Head and neck cancer; HPV; Nasopharyngeal carcinoma; Tonsillar carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN E6; PROTEIN E7; PROTEIN P16;

CANCER INCIDENCE; CLINICAL FEATURE; DRINKING; EPSTEIN BARR VIRUS; GENE EXPRESSION; HEAD AND NECK TUMOR; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT TRANSFORMATION; MOUTH CARCINOMA; NASOPHARYNX CARCINOMA; REVIEW; RISK FACTOR; SMOKING; TONSIL CANCER; VIRUS CARCINOGENESIS; VIRUS ONCOGENE; WART VIRUS;

EPSTEIN-BARR VIRUS INFECTIONS; HEAD AND NECK NEOPLASMS; HERPESVIRUS 4, HUMAN; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 1242339615     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-003-0669-y     Document Type: Review

References (42)

1. Aaltonen LM, Rihkanen H, Vaheri A (2002) Human papillomavirus in larynx. Laryngoscope 112: 700-707
2. INK4a antigen in thin-layer, liquid-based specimens. Acta Cytol 46: 25-29
3. Bouda M, Gorgoulis VG, Kastrinakis NG et al.(2000) "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 13: 644-653
4. Chan KH, Gu YL, Ng F et al.(2003) EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J Cancer 105: 706-709
5. Cheng WM, Chan KH, Chen HL et al. (2002) Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. Int J Cancer 97: 489-492
6. Duensing S, Munger K (2001) Centrosome abnormalities, genomic instability and carcinogenic progression. Biochim Biophys Acta 1471: M81-M88
7. Galloway DA (2003) Papillornavirus vaccines in clinical trials. Lancet Infect Dis 3: 469-475
8. Giovannelli L, Campisi G, Lama A et al. (2002) Human papillomavirus DNA in oral mucosal lesions. J Infect Dis 185: 833-836
9. Hohenberger P, Gretschel S (2003) Gastric cancer. Lancet 362: 305-315
10. Hubbard RA (2003) Human papillomavirus testing methods. Arch Pathol Lab Med 127: 940-945
11. Klaes R, Woerner SM, Ridder R et al. (1999) Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 59: 6132-6136
12. Klaes R, Friedrich T, Spitkovsky D et al. (2001) Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92: 276-284
13. INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 26: 1389-1399
14. Klussmann JP, Gultekin E, Weissenborn SJ et al. (2003) Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 162: 747-753
15. Lo YM, Chan LY, Chan AT et al. (1999) Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 59: 5452-5455
16. Loren AW, Porter DL, Stadtmauer EA, Tsai DE (2003) Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant 31: 145-155
17. Luft F, Klaes R, Nees M et al. (2001) Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIP5-PCR) and molecular characterization in cervical cancer cells. Int J Cancer 92: 9-17
18. Macsween KF, Crawford DH (2003) Epstein-Barr virusrecent advances. Lancet Infect Dis 3: 131-140
19. Mantovani F, Banks L (2001) The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20: 7874-7887
20. McKaig RG, Bario RS, Olshan AF (1998) Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 20: 250-265
21. Mellin H, Dahlgren L, Munck-Wikland E et al. (2002) Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102: 152-158
22. Moody CA, Scott RS, Su T, Sixbey JW (2003) Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergence. J Virol 77: 8555-8561
23. Munger K, Basile JR, Duensing S et al. (2001) Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20: 7888-7898
24. INK4a as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 56: 56-63
25. Mutiu A, Alexiu I, Chivu M et al.(2001) Detection of human papillomavirus gene sequences in cell lines derived from laryngeal tumors. J Cell Mol Med 5: 49-59
26. INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 27: 187-193
27. Ohga S, Nomura A, Takada H, Hara T (2002) Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol 44: 203-215
28. Raab-Traub N (2002) Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12: 431-441
29. Rickinson A (2002) Epstein-Barr virus. Virus Res 82: 109-113
30. Ritchie JM, Smith EM, Summersgill KF et al. (2003) Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104: 336-344
31. Rosin MP, Anwar WA, Ward AJ (1994) Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res 54: 1929s-1933s
32. Strome SE, Savva A, Brissett AE et al. (2002) Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res 8: 1093-1100
33. Sugiyama M, Bhawal UK, Dohmen T et al. (2003) Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 594-600
34. Takada K (2000) Epstein-Barr virus and gastric carcinoma. Mol Pathol 53: 255-261
35. Takada K (2001) Role of Epstein-Barr virus in Burkitt's lymphoma. Curr Top Microbiol Immunol 258: 141-151
36. Tsuchiya S (2002) Diagnosis of Epstein-Barr virus-associated diseases. Crit Rev Oncol Hematol 44: 227-238
37. Wentzensen N, Ridder R, Klaes R et al. (2002) Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene 21: 419-426
38. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX (2002) Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21: 1510-1517
39. Young LS, Murray PG (2003) Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22: 5108-5121
40. zur Hausen H (1999) Viruses in human cancers. Eur J Cancer 35: 1878-1885
41. zur Hausen H (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92: 690-698
42. zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350